Alvotech (ALVO)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Alvotech (ALVO) is down 41.5% since the beginning of the year. At $3 per share, ALVO is trading 73.0% below its 52-week high of $11.

Alvotech (ALVO) has returned -41.52% so far this year and -73.80% over the past 12 months.

Based on dividend-adjusted daily data since Jun 16, 2022, ALVO's average daily return is -0.06%, while the average monthly return is -1.14%.

Historically, 39% of months were positive and 61% were negative. The best month was Dec 2022 with a return of +58.7%, while the worst month was Nov 2025 at -33.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 4 months.

On a daily basis, ALVO closed higher 47% of trading days. The best single day was Aug 15, 2022 with a return of +18.6%, while the worst single day was Nov 3, 2025 at -34.3%.

Alvotech has an annualized alpha of -23.57%, beta of 0.58, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since June 17, 2022.

• This stock participated in 42.64% of S&P 500 Index downside but only -56.72% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.58 may look defensive, but with R2 of 0.03 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ALVO ranks 3 for risk / return — in the bottom 3% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Alvotech (ALVO) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Alvotech. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alvotech was 82.63%, occurring on Jun 2, 2026. The portfolio has not yet recovered.

The current Alvotech drawdown is 82.63%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Alvotech over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Alvotech is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.